Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

120 CHURCH STREET ASSOCIATION

UEI: E79UCQGXV2J4

120 CHURCH STREET ASSOCIATION is a federal contractor, registered under UEI E79UCQGXV2J4. It has been awarded $24,175 across 2 federal contracts. Primary work spans Medical Laboratories. Top awarding agencies include Department Of Justice.

Contact Information

Registration and classification details

Registration

UEI Code

E79UCQGXV2J4

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Justice$24.2K100%

Awards by NAICS

621511 - Medical Laboratories$24.2K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in 120 CHURCH STREET ASSOCIATION's top NAICS codes and agencies

Genotyping Analysis ServicesThe US Army Research Institute of Environmental Medicine, under the Defense Health Agency, is soliciting genotyping analysis services for 648 blood samples collected as part of the Military Health and Nutrition Examination Survey. The contract requires a vendor to perform large-scale, high-density array-based genotyping using the Illumina Global Diversity Array, which assays approximately 1.8 million genome-wide Single Nucleotide Polymorphisms to support population genetics, ancestry inference, polygenic score calculation, and genome-wide association studies. The work is governed by a Firm-Fixed Price contract with a one-year performance period from August 4, 2026, to August 3, 2027, and delivery is to be made to the specified location in Natick, Massachusetts. All services must adhere to Good Laboratory Practice standards, comply with the NIH “All of Us” Research Program protocols, and ensure 100% analytical accuracy with no more than one customer complaint. The contractor must submit a Quality Control Plan within 15 days of award and maintain compliance with cybersecurity and data safeguarding requirements including DFARS 252.204-7012 and 252.204-7008, as well as the Federal Acquisition Regulation’s data protection clauses. The vendor must have prior experience delivering genomic services to the federal government involving at least 10,000 samples and cannot subcontract more than 50% of the effort. Proposals must be submitted electronically via email to the point of contact, structured into two volumes with a strict 10-page limit on the technical approach, formatted in Times New Roman size 10 or larger, and must exclude zip files due to security restrictions. Award will be determined on a trade-off basis, with Technical Approach and Past Performance evaluated as threshold factors; only offers rated Acceptable in both will proceed to price evaluation, where reasonableness and overall value will determine the selection. Invoicing must be submitted through Wide Area WorkFlow, and the contractor must maintain active System for Award Management registration with a Valid Unique Entity Identifier and CAGE code. All work is classified as UNCLASSIFIED, though security protocols for handling genetic data require strict compliance with federal safeguarding mandates.

Defense Health Agency

POSTED

about 11 hours ago

DEADLINE

Q301--New - VISN Specialty Testing ServicesThis solicitation, numbered 36C25726Q0787, is a combined synopsis and request for quotation for commercial urinalysis CPRR services across multiple locations within Veterans Integrated Service Network 17, with a total estimated value of $41.5 million under NAICS code 621511. No set-aside is in place, and the acquisition is conducted under FAR Part 12 procedures for commercial items, with provisions and clauses in effect through Federal Acquisition Circular 2026-01. Offerors must comply with the evaluation criteria of technical acceptability, past performance, and price as outlined in the attached RFQ document and the supplemental Addendum to FAR 52.212-1; failure to submit the minimum required documentation will result in immediate technical rejection. The contract will be awarded as an indefinite quantity contract with options to extend services, governed by commercial terms and conditions without addenda to FAR 52.212-4. Numerous clauses and provisions apply to ensure compliance with federal employment, subcontracting, ethics, and procurement standards, including those related to small business utilization, labor rights, whistleblower protections, anti-trafficking, equal opportunity, paid sick leave, and cybersecurity. Several deviations are authorized to tailor requirements to the Department of Veterans Affairs, including specific provisions for VA small business subcontracting and compliance with Executive Orders on labor standards and diversity, equity, and inclusion. All proposals must be submitted electronically to Delphia Schoenfeld by September 14, 2026, at 3 PM Eastern Time, and any inquiries must be received by August 20, 2026. Entities must register in and maintain an active System for Award Management account, though outdated or irrelevant SAM representations, such as affirmative action filings, will not affect evaluate or award decisions. Payment will be made via electronic funds transfer, with accelerated payments required for small business subcontractors, and all performance is subject to continuity of service and cybersecurity security prohibitions.

257-NETWORK Contract Office 17 (36C257)

POSTED

about 11 hours ago

DEADLINE

in about 2 months

Missouri State Newborn Testing

POSTED

DEADLINE

RFP No. 26-2973-7JOK - Multi-Cancer Early Detection Testing ServicesHenrico County Government in Virginia is seeking qualified firms to provide multi-cancer early detection testing services under RFP No. 26-2973-7JOK, issued as solicitation number RFP-124678. The opportunity, posted on July 20, 2026, requires proposers to deliver testing services aligned with the detailed Scope of Services outlined in the solicitation, focusing on early detection capabilities for multiple types of cancer. Responses are due by August 4, 2026, at 4:00 PM Eastern Time, and the contract will be awarded based on the vendor’s ability to meet technical, operational, and compliance requirements specified in the RFP. The services are intended for performance within Henrico County, Virginia, and are managed by the county’s SLED-type organization, with Joseph Knott serving as the point of contact for inquiries, reachable via email at kno008@henrico.gov or phone at 804-501-5649. All proposals must be submitted through the designated vendor portal linked in the solicitation details.

Henrico County Government

POSTED

DEADLINE

Diagnostic Investigation Services (Lab & Imaging)The contract calls for the provision of diagnostic investigation services including clinical laboratory testing and medical imaging to support the assessment and management of diseases among inmates within correctional facilities across Canada, excluding the National Capital Region in Ontario. All procedures must adhere to clinically accepted standards and employ minimally invasive methods to ensure patient safety and compliance with healthcare protocols. The services are intended to facilitate timely and accurate medical evaluations necessary for ongoing inmate care under the jurisdiction of the Correctional Service of Canada, which is acting on behalf of the Government of Canada. The opportunity is structured as a subcontract with a NAICS code of 621511, indicating alignment with medical and diagnostic laboratory services. The solicitation was posted on July 20, 2026, with a response deadline of August 10, 2026. Performance is expected to occur across facilities in the national territory, with specific emphasis on locations outside the National Capital Region of Ontario. There is no set-aside designation specified, meaning the contract is open to all qualified bidders regardless of business size or status. Interested parties must submit proposals before the deadline to be considered for award, and all work must be conducted in accordance with federal correctional healthcare requirements and standards. The full details and submission instructions are available through the official Canada Buys portal.

Correctional Service of Canada

POSTED

DEADLINE

Subcontracted Reference Laboratory ServicesThe contract titled Subcontracted Reference Laboratory Services pertains to the outsourcing of high-complexity or infrequent diagnostic testing services to third-party reference laboratories, with specific emphasis on specialized areas such as virology and genetic assays, and includes LabCorp as a designated provider. The solicitation is open for submissions with a response deadline of July 27, 2026, and is classified as a subcontract under NAICS code 621511, which corresponds to medical and diagnostic laboratories. The contracting agency is identified as LANSING, operating under the Michigan state organization, though no specific office address or point of contact details are provided. The place of performance and other logistical specifics are undetermined, suggesting the services may be delivered remotely or across multiple locations as needed by the testing requirements. No set-aside provisions are indicated, meaning the contract is open to all eligible subcontractors without restrictive classifications based on business size or ownership. Interested parties must submit proposals via the provided public portal prior to the deadline to be considered for award, and the nature of the services implies a need for advanced laboratory capabilities, regulatory compliance, and precise result reporting for public health or clinical applications.

POSTED

DEADLINE

Clinical Laboratory Testing ServicesThe contract outlines the provision of clinical laboratory testing services under a subcontract arrangement, requiring the execution of a standardized panel of diagnostic assays including metabolic panels, renal function tests, hepatitis screening, complete blood counts, and other CPT-coded laboratory procedures. These services are intended for billing purposes using accepted CPT codes and must be performed according to established clinical and regulatory standards. The solicitation was posted on July 20, 2026, with a firm response deadline of July 27, 2026, and is classified under NAICS code 621511, which corresponds to medical and diagnostic laboratories. The contracting entity is identified as LANSING through the Michigan agency, though specific location details such as city, state, or zip code for performance or contact are not provided. The work is to be conducted under the terms of the subcontract, and all participants are expected to comply with applicable billing, reporting, and quality protocols without additional set-aside specifications. Access to further details is available via the provided online portal.

POSTED

DEADLINE

NIA1-491-260000000655-2 | Notice of Intent to Award RFP 260000001866The Michigan Department of Health and Human Services is proceeding with an award to Biotech Clinical Laboratories, Inc. for a three-year contract with two optional renewal periods to provide comprehensive on-site laboratory services across state-operated psychiatric facilities, primarily Caro Psychiatric Hospital and Walter P. Reuther Psychiatric Hospital. The contract, issued under solicitation NIA1-491-260000000655-2, mandates end-to-end laboratory operations including specimen collection, phlebotomy, STAT and routine testing, transportation, and seamless electronic interfacing with state systems like Netsmart, all governed by documented standard operating procedures and compliance with CPT codes and Michigan DHHS policies. Evaluation of proposals was based on a trade-off approach valuing technical merit over lowest price, with 100 total points allocated across sections of the Statement of Work covering specimen handling, testing protocols, staffing commitments, and vendor responsiveness, where bidders were scored numerically—Biotech achieved the highest combined score, leading to the recommended award of $3,000,000. Performance must be delivered on-site at designated facilities in Michigan, with the contractor bearing all transportation costs and risks associated with specimen handling, implying FOB Origin terms by practice though not formally stated. Contractor personnel are required to comply with state-issued badge protocols and maintain full transparency on subcontractor relationships, as deficiencies in disclosing third-party arrangements, such as the use of LabCorp, resulted in evaluation penalties. The solicitation did not include formal FAR clauses, contract administration details, payment or invoicing instructions, or federal accounting codes, and while key personnel time commitments and backup continuity plans were required, offerors submitted incomplete responses in these areas. The procurement leveraged the SIGMA VSS portal for electronic submissions, with proposals due June 19, 2026, and no set-aside classifications or socioeconomic certifications were claimed or verified for either Biotech or Vibra Health Lab, the two responding entities.

POSTED

DEADLINE

Infectious Disease Testing ServicesIntegral Care is seeking qualified providers to deliver diagnostic testing services for HIV, Hepatitis B and C, tuberculosis, sexually transmitted infections, and other communicable diseases specifically within behavioral health populations. The contract is structured as a subcontract with a response deadline of August 7, 2026, and is categorized under NAICS code 621511, indicating it pertains to medical and diagnostic laboratories. Testing must be conducted in a manner that accommodates the unique needs of individuals receiving behavioral health services, ensuring accessibility, confidentiality, and cultural competence. The scope includes sample collection, laboratory analysis, result reporting, and linkage to care, with performance expected to align with public health standards and best practices for high-risk and underserved communities. No set-aside provisions are indicated, and the place of performance and office address details are unspecified, suggesting services may be delivered across Texas through mobile units, clinics, or partnerships with behavioral health facilities. Interested parties must review the full solicitation via the provided Texas SmartBuy portal link.

POSTED

DEADLINE

Toxicology and Drug Screening ServicesIntegral Care is seeking a subcontractor to provide comprehensive urine and blood toxicology testing services, including chain-of-custody procedures and STAT screening for substance use in crisis admission scenarios. The contract requires timely, accurate, and compliant laboratory analysis supporting behavioral health and emergency response efforts, with strict adherence to federal and state regulatory standards for sample handling and reporting. Services must be available to meet urgent clinical needs, ensuring rapid turnaround for critical patient care decisions. The opportunity is open to qualified vendors who can demonstrate experience in forensic and clinical toxicology, with the capacity to manage high-volume testing under time-sensitive conditions. Interested parties must submit responses by August 7, 2026, through the TX SmartBuy portal, and the work is expected to be performed in Texas under the oversight of Integral Care. The contract falls under NAICS code 621511, indicating it targets medical and diagnostic laboratories, and no set-aside provisions are specified, making it open to all eligible contractors.

POSTED

DEADLINE

Core Clinical Laboratory Testing ServicesIntegral Care is seeking a subcontractor to provide routine and specialized clinical laboratory testing services specifically for behavioral health patients, including complete blood counts, comprehensive metabolic panels, and lipid panels. The contract, titled Core Clinical Laboratory Testing Services, is posted under NAICS code 621511 and is available through the Texas SmartBuy portal, with a response deadline of August 7, 2026. The services are expected to support patient care within the behavioral health system in Texas, though the exact performance location is not specified. This opportunity is open to qualified providers who can ensure accurate, timely, and compliant lab testing aligned with clinical standards for this population.

POSTED

DEADLINE

Comprehensive Clinical Laboratory Testing and On-Site Specimen Collection ServicesIntegral Care is soliciting proposals for comprehensive clinical laboratory testing and on-site specimen collection services to support individuals receiving behavioral health and community-based care in Texas. The selected provider will deliver a wide range of diagnostic laboratory services including blood panels, hematology, endocrine testing, urinalysis, toxicology and drug screening, therapeutic drug monitoring, infectious disease testing, STI and HIV screening, tuberculosis testing, and other medically necessary diagnostics. The provider must demonstrate the ability to handle high-volume testing demands with reliable turnaround times for routine and expedited services such as CBC, A1C, lipid panels, comprehensive metabolic panels, thyroid testing, and urine toxicology. STAT and rapid testing options with clearly defined timelines are required to support crisis stabilization, medication management, and clinical decision-making. Proposals must detail operational capacity, staffing, equipment, and logistical capabilities to ensure consistent, high-quality service delivery across multiple community-based locations. All questions must be submitted by Monday, July 27, 2026, and proposals are due no later than Friday, August 7, 2026, at 5:00 p.m. Central Daylight Time. The solicitation is managed by Integral Care in Austin, Texas, with primary contacts listed for inquiries and correspondence.

POSTED

DEADLINE

After-Hours and Reasonable Suspicion TestingThe contract requires a vendor to provide on-demand drug and alcohol testing services during non-business hours to address safety incidents or observed signs of impairment, with a strict mandate for 24/7 availability and rapid response capabilities. Testing must be conducted promptly following an incident or suspicion of impairment, and all results must be delivered on the same day to ensure timely decision-making and regulatory compliance. The service must support a safety-sensitive environment where immediate intervention is critical, and the vendor is expected to maintain high operational readiness without disruption. This subcontract, classified under NAICS code 621511 for medical and diagnostic laboratories, is issued by the Florida Finance agency and is open for responses until August 14, 2026. The place of performance and specific location details are not specified, indicating flexibility in service delivery across the state. The vendor must demonstrate proven experience in emergency testing protocols, secure chain-of-custody procedures, and the ability to integrate seamlessly into existing safety and compliance frameworks. There is no set-aside specification, meaning the opportunity is open to all qualified entities regardless of business size or ownership structure.

POSTED

DEADLINE

Follow-Up Drug TestingThe contract requires the provision of scheduled follow-up drug testing for employees subject to post-violation monitoring, ensuring compliance through unannounced testing at predetermined intervals to maintain integrity and deterrence. Testing must be conducted reliably and consistently, with strict protocols in place to ensure chain of custody and result accuracy. Long-term data retention is a critical component, as all test records must be securely stored for extended periods to support future audits, regulatory reviews, and compliance verification. The scope is limited to services under a subcontract, tied to the NAICS code 621511 for medical laboratories, and is administered by the Florida Finance agency with a response deadline of August 14, 2026. There is no specified place of performance or point of contact, indicating the service may be delivered remotely or across multiple locations within the state.

POSTED

DEADLINE

Fitness-for-Duty / Return-to-Work TestingThe contract pertains to conducting drug and alcohol testing for employees returning to work after medical leave, rehabilitation, or injury, ensuring compliance with City occupational health protocols and reporting standards. The testing program must be fully integrated with existing municipal health and safety procedures to support safe and responsible workforce reintegration. It is classified as a subcontract under NAICS code 621511, indicative of medical and diagnostic laboratories, and is issued by the Finance agency of Florida. The opportunity was posted on July 17, 2026, with a response deadline of August 14, 2026. While specific performance location details are not provided, the work is expected to align with City-wide operational requirements. All submissions must be made through the designated online portal prior to the deadline.

POSTED

DEADLINE

Random Drug Testing ServicesThe contract requires the provision of random drug testing services for City employees, encompassing full-cycle support including on-site specimen collection, strict chain-of-custody documentation, laboratory analysis, and accurate reporting in full alignment with federal and state regulatory standards. Compliance with Department of Transportation, Nuclear Regulatory Commission, and Florida Statutes is mandatory, ensuring all procedures meet the highest legal and operational benchmarks for workplace safety and regulatory accountability. Services must be delivered on a scheduled, unpredictable basis to maintain the integrity of the testing program, with all data handled securely and reported in a timely manner to authorized personnel. The contract is structured as a subcontract under the Finance department of the State of Florida, with a North American Industry Classification System code of 621511, indicating focus on medical and diagnostic laboratories. The solicitation is open for responses until August 14, 2026, and performance is expected to occur within the jurisdictional boundaries governed by Florida law, though specific location details for the place of performance are not defined in the available data.

POSTED

DEADLINE

Q301--Intent to Sole Source Specialized laboratory medical testing servicesThe Department of Veterans Affairs, through Network Contract Office 21, intends to award a sole source firm fixed price contract to Mayo Collaborative Services, Inc. for specialized laboratory medical testing services, with a base year and up to four additional option years, based on the determination that Mayo is the only authorized provider capable of performing the required tests. These services include highly specialized assays such as neuromyelitis optica/Aquaporin-4 FACS IgG titer, myelin oligodendrocyte glycoprotein FACS titer, glutamic acid decarboxylase antibody testing in spinal fluid, and several other neural and paraneoplastic antibody analyses performed on serum and body fluids. The contracting office asserts that no other entity is authorized or capable of delivering these exact testing methodologies, justifying the sole source approach under NAICS code 621511 with a size standard of $41.5 million. Interested parties may respond if they believe they can meet the requirements outlined in the attached Statement of Work, but must submit both their capabilities and an explicit authorization letter from Mayo Collaborative Services, Inc. to angela.gerlitzki1@va.gov no later than July 24, 2026, at 10 a.m. PST. This notice is not a solicitation for competition and the government retains full discretion to proceed without a competitive process regardless of responses received.

261-NETWORK Contract Office 21 (36C261)

POSTED

DEADLINE

Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodulesThe contract pertains to Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodules, aiming to support diagnostic precision through advanced genomic analysis. It is issued under solicitation number 75N98026Q00822 by the National Institutes of Health Olao, a component of the Department of Health and Human Services, with the NAICS code 621511 indicating alignment with medical laboratories and diagnostic services. The solicitation was posted on July 17, 2026, with a response deadline of July 27, 2026, and performance is expected to occur in Bethesda, Maryland, where the office is located at 20892. James B. Law serves as the primary point of contact, reachable via email at james.law@nih.gov, and all submissions must be made through the SAM.gov portal referenced in the provided link. The contract does not specify any set-aside provisions, indicating it is open to all eligible offers without preference or restriction.

National Institutes Of Health Olao

POSTED

DEADLINE